Consulting Services for Medical and Scientific Technologies
Market Research and Analytics

Gain an Edge with Custom IVD Market Research

Global clients in in vitro diagnostics, as well as life science research and pharmaceuticals, use MDxI’s proven research methods to gain an edge in understanding clinical laboratory market opportunities.

Learn More
Strategic Positioning and Planning

Strategically Pursue Healthcare Market Opportunities

Pursue market opportunities with confidence. MDxI’s consulting services build on a solid foundation of specialized IVD market knowledge, custom research and analysis, and proprietary IVD syndicated databases covering more than 500 analytes in 10 lab disciplines.

Learn More
Syndicated Data Services

Leverage IVD Syndicated Data for Insightful Decisions

MDxI has exclusive access to College of American Pathologists’ Proficiency Testing data for strategic market analyses, as well as clinical lab census and other data to help clients identify, target, find, and reach customers - and opportunities - with greater accuracy.

Learn More


Larry Worden Announces Retirement

Dallas, TX, April 7, 2017. MDxI CEO Kathi McGregor announces the retirement of Larry Worden, Founding Partner and President, from day-to-day operations of the company. Larry has been instrumental in the growth of the company over the past nine years and will remain a shareholder in the company. He will continue to leverage his 35+ years in the industry as a private consultant and speaker at industry meetings.

Please contact Kathi at 972-419-1575 or This email address is being protected from spambots. You need JavaScript enabled to view it. with any questions, or if you would like Larry’s contact information.

Mike Daniel Promoted to President

Dallas, TX, April 7, 2017. MDxI CEO Kathi McGregor announces the promotion of Mike Daniel, CTO, to President. Mike has 25+ years in the Information Technology industry and has been with MDxI for over 11 years. His background in systems integration, data analysis, and database administration has been instrumental in the development of our current data products. Mike will be spearheading our new Customer Relationship Management (CRM) consulting offering, as well as managing the company in partnership with Kathi.

MDxI Moves to New Offices

Dallas, TX, December 14, 2016. To accommodate our continued growth in providing IVD companies with the most definitive and complete information on the markets they serve, MDxI is relocating its offices effective January 30, 2017. We look forward to serving you from our new home at:
Park Central 7•8•9
12750 Merit Drive
Suite 825
Dallas, TX 75251

Our phone number, email and website will remain unchanged.

MDxI's Larry Worden Featured Speaker at the Association For Molecular Pathology's 5th Annual Analyst Day Forum

Dallas, TX, September 12, 2016. Larry Worden, Vice President and Senior Partner of Market Diagnostics International LLC (“MDxI”) will deliver an overview of the worldwide molecular diagnostics market to leading molecular diagnostics-focused analysts and private equity executives at the 5th annual Association for Molecular Pathology (“AMP”) Analyst Day, to be held in conjunction with this year’s annual meeting in Charlotte, NC. This is the fifth annual update that MDxI will provide to the attendees at this meeting.
Read More

Larry Worden to Moderate Expert Panel Discussion at the 7th World Boston CDx 2016

Dallas, TX, September 9, 2016. MDxI’s Vice President and Senior Partner, Larry Worden, will moderate an expert panel discussion on “Addressing the Challenges to Commercial Success for your CDx” at the 7th World CDx Boston Summit 2016 on Monday, October 18th.
Read More

MDxI To Present “Establishing The Value Of Diagnostic Tests” At The Next Generation Dx Summit

Dallas, TX, August 16, 2016. MDxI has organized a “Short Course” entitled “Establishing the Value of Diagnostic Tests” to be offered in conjunction with the eighth annual Next Generation Dx Summit being held on August 22-26, 2016 in Washington D.C.
Read More

DxMA Elects Lawrence Worden As President and Debra Harrsch As President-Elect

Dallas, TX, January 4, 2016. The Diagnostic Marketing Association (DxMA) is pleased to announce the election of Lawrence Worden of Market Diagnostics International, as president and Debra Harrsch of Brandwidth Solutions as president-elect to two-year terms running through the end of 2017. Also elected to two-year leadership positions were Ned Gordon of Siemens Healthcare Diagnostics who will serve as treasurer and Narayan Krishnaswami of MilliporeSigma as secretary.
Read More

MDxI To Present At The ASM/AMP Analyst Symposium

Dallas, TX, December 22, 2015. Larry Worden, Vice President and Senior Partner of Market Diagnostics International LLC (“MDxI”) will deliver an overview of the key trends in the infectious disease testing market to leading infectious disease diagnostics-focused analysts at the Analyst Symposium sponsored by the American Society for Microbiology (ASM) and Association for Molecular Pathology (“AMP”) Analyst Symposium, to be held in conjunction with the 34th Annual J.P. Morgan Healthcare Conference on January 13, 2016.
Read More

IVD Insights™ Reports

View All

IVD Insights™ LabFile